Abstract:Abstract Background The prognosis of colon cancer is poor for metastasis, while the mechanism, especially adipocytes related, is not yet clear. The purpose of this study is to determine the effects of fatty acid binding protein 4 (FABP4), a transporter for lipids, on colon cancer progression. Methods The distribution of lipids and FABP4 was tested in the colon cancer tissues and adjacent normal tissues, and their relationship was also verified in vitro. Experiments about cellular invasion, migration and proliferation were performed to detect the impacts of FABP4 on the biological behaviors of colon cancer, and the positive results were checked in vivo. Meanwhile, the regulatory role of FABP4 in the energy and lipid metabolism was evaluated by the levels of triglyceride, ATP, LDH, glycerol and NEFA. At last, GO and KEGG analysis based on FABP4 overexpressed cells was performed, and the AKT pathway and epithelial–mesenchymal transition (EMT)-related proteins were determined by Western blot. Results Higher accumulation of lipids and stronger FABP4 transcription were observed in colon cancer tissues. Having been incubated with adipose tissue extract and overexpressed FABP4, colon cancer cells demonstrated enhanced lipid accumulation. In functional experiments, co-culture with adipose tissue extract significantly enhanced the invasion and migration of colon cancer cells, as well as the energy and lipid metabolism, and all these processes were reversed by FABP4 inhibitor. In addition, the metastasis of FABP4-overexpressed colon cancer cells was also significantly enhanced in vitro and in vivo. In terms of mechanism, the bioinformatics analysis showed that FABP4 was enriched in 11 pathways related to metabolic processes in FABP4 overexpressed cells. Finally, FABP4 overexpression improved EMT progression of colon cancer, as evidenced by the upregulation of Snail, MMP-2 and MMP-9, the downregulation of E-cadherin. The expression of p-Akt was also elevated. Conclusion FABP4 overexpression could increase FAs transport to enhance energy and lipid metabolism, and activate AKT pathway and EMT to promote the migration and invasion of colon cancer cells.

Fatty acid‐binding protein 5 controls lung tumor metastasis by regulating the maturation of natural killer cells in the lung

FABP5 Promotes Lymph Node Metastasis in Cervical Cancer by Reprogramming Fatty Acid Metabolism.

FABP5 correlates with poor prognosis and promotes tumor cell growth and metastasis in cervical cancer

FABP5 Enhances Malignancies of Lower‐grade Gliomas Via Canonical Activation of NF‐κB Signaling

Fas Signaling in Adipocytes Promotes Low-Grade Inflammation and Lung Metastasis of Colorectal Cancer Through Interaction with Bmx.

FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway

FABP5+ lipid-loaded macrophages process tumor-derived unsaturated fatty acid signal to suppress T-cell antitumor immunity

Fatty Acid-Binding Protein 5 Predicts Poor Prognosis in Patients with Uveal Melanoma.

Metastatic Tumor Cell-Specific FABP7 Promotes NSCLC Metastasis via Inhibiting -Catenin Degradation

Metastatic Tumor Cell-Specific FABP7 Promotes NSCLC Metastasis via Inhibiting β-Catenin Degradation

Fatty acid binding protein 5 suppression attenuates obesity-induced hepatocellular carcinoma by promoting ferroptosis and intratumoral immune rewiring

FABP4 promotes invasion and metastasis of colon cancer by regulating fatty acid transport

Fatty Acid Binding Protein 5 Promotes the Proliferation, Migration, and Invasion of Hepatocellular Carcinoma Cells by Degradation of Krüppel-like Factor 9 Mediated by Mir-889-5p Via Camp-Response Element Binding Protein

Advances in fatty acid metabolism reprogramming of lung cancer

Lipid-related FABP5 Activation of Tumor-Associated Monocytes Fosters Immune Privilege Via PD-L1 Expression on Treg Cells in Hepatocellular Carcinoma

SOX5 Predicts Poor Prognosis in Lung Adenocarcinoma and Promotes Tumor Metastasis Through Epithelial-Mesenchymal Transition

Fatty-acid-induced FABP5/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells

Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4

Identification of FABP5 As an Immunometabolic Marker in Human Hepatocellular Carcinoma

Suppression of Tumor Progression and Angiogenesis in Two Lewis Lung Carcinoma Mouse Models by Shrna Knockdown of Fibroblast Activation Protein.

Ligand Bound Fatty Acid Binding Protein 7 (FABP7) Drives Melanoma Cell Proliferation Via Modulation of Wnt/β-Catenin Signaling